Promethera Biosciences is a global innovator in liver therapeutics whose mission is to enable patients to overcome acute and chronic liver diseases. Our lead clinical program, derived from our patented cell technology platform HepaStem, is designed to benefit from its immune-modulatory and anti-fibrotic properties. In addition to our cell-based pipeline we develop antibody technologies, such as the anti-TNF-R1 antibody Atrosimab, to complement and diversify our therapeutic options. We are a team of international experts operating out of R&D and GMP facilities in Mont-Saint-Guibert, Belgium, and Durham, NC, USA.
State of Ownership
Independent Worker, Service Provider, [ (...) (e.g. Accountant / Auditor / Among others professional titles)], SBT, Serafim Bastos Tavares (SBT)
Business Development Executive, Nature Publishing Group, Springer Nature